Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

AVMA Response To PETA Protest At The Association's Annual Convention
The American Veterinary Medical Association (AVMA) respects and values PETA"s right to express an opinion and hold a peaceful demonstration at our 146th Annual Convention in Seattle. On the other hand, we disagree with their position on our use of fish during an educational and motivational presentation by the fishmongers of Pike Place Fish Market.
generic viagra online
Xeloda(R)-Oxaliplatin Combination (XELOX) Shown To Be More Effective Than Standard Chemotherapy Regimen In Adjuvant Colon Cancer
Genentech, Inc. announced that an international Phase III study demonstrated that oral Xeloda® plus oxaliplatin (XELOX) is superior to a commonly used intravenous chemotherapy, 5-FU/LV (infused 5-fluorouracil plus leucovorin), in increasing the time people with adjuvant colon cancer lived without their cancer returning when given immediately after surgery. The data show those who participated in the study and took XELOX immediately after surgery lived longer without their cancer being detectable than those who took intravenous 5U/LV. No new adverse events related to Xeloda were observed in the study.
News of the day
ACSM Addresses U.S. And World Business Community At NASDAQ Stock Market Close
The American College of Sports Medicine (ACSM), the world"s largest sports medicine and exercise organization, rang the closing bell at the NASDAQ stock market last week (Wednesday, May 6), using the international platform to promote the health benefits of physical activity, especially for businesses and employers in the U.S. and worldwide.
Nutrition

CardioNet Announces Launch Of Clinical Indicator For Sleep Disorders

CardioNet, Inc. (NASDAQ:BEAT) announced the launch of SomNet ™, a new clinical indicator available in the Company"s existing Mobile Cardiac Outpatient Telemetry™ (MCOT™) system. Because many patients with cardiac disorders also suffer from common sleep disorders like sleep apnea, CardioNet believes that SomNet has the potential to identify patients with a high likelihood of such sleep disorders by measuring cyclic variation of heart rate (CVHR), a rhythm that is caused by repeated arousals from sleep due to such disorders. SomNet"s utility is based on data presented at the Heart Rhythm Society"s (HRS) 30th Annual Scientific Sessions in Boston. "There is a high prevalence of sleep disorders like sleep apnea in the cardiovascular and arrhythmia population," said Randy Thurman, CEO of CardioNet. "The data collected by SomNet is extremely valuable information that can be captured from our existing MCOT ECG signal. If clinically appropriate, physicians may choose to refer patients with CVHR patterns to sleep centers for further diagnostic testing, to determine if they have sleep apnea or another serious sleep disorder." In an 80-patient study presented today at HRS, Phyllis K. Stein, Ph.D., Research Associate Professor of Medicine at Washington University School of Medicine, found that automated identification of clinically relevant CVHR is feasible using CardioNet"s MCOT system. The study compared MCOT automatic analysis of CVHR patterns versus a human expert"s direct analysis of plots of HR patterns for measuring clear (large amplitude) CVHR. Findings showed similar specificity and positive predictive value measures between MCOT and human expert analysis, with slightly lower sensitivity measures for the automated analysis. "Although slightly less sensitive than more labor intensive human overreading, the MCOT system and SomNet may provide a platform for efficiently identifying patients with severe sleep disorders, like sleep apnea, in a large population," said Dr. Stein. CardioNet, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009